An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress

Hypertension

Volumn 63, Issue 5, 2014, Pages 1056-1062

  Smillie, Sarah Jane ^a   King, Ross ^a   Kodji, Xenia ^a   Outzen, Emilie ^b   Pozsgai, Gabor ^a   Fernandes, Elizabeth ^a   Marshall, Nichola ^a   De Winter, Patricia ^c   Heads, Richard J ^a   Dessapt Baradez, Cecile ^a   Gnudi, Luigi ^a   Sams, Anette ^b   Shah, Ajay M ^a   Siow, Richard C ^a   Brain, Susan D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiotensin II; Calcitonin gene related peptide; Hypertension; Hypertrophy; Mice; Nitric oxide; Oxidative stress

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 HYDROXYNONENAL; ALPHA CALCITONIN GENE RELATED PEPTIDE; ANGIOTENSIN II; CARBACHOL; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIN; GLUTATHIONE PEROXIDASE 1; HEME OXYGENASE 1; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL HYPERTROPHY; BLOOD VESSEL REACTIVITY; BODY WEIGHT; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HYPERTENSION; HYPERTROPHY; MESENTERIC ARTERY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESISTANCE BLOOD VESSEL; SPINAL GANGLION; UPREGULATION; VASCULAR DISEASE;

ANGIOTENSIN II; CALCITONIN GENE-RELATED PEPTIDE; HYPERTENSION; HYPERTROPHY; MICE; NITRIC OXIDE; OXIDATIVE STRESS;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; DISEASE MODELS, ANIMAL; ENDOTHELINS; HYPERTENSION; HYPERTROPHY; MESENTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84902297961     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02517     Document Type: Article

References (41)

1. Brain SD, Williams TJ, Tippins J.R., Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985; 313: 54-56. (Pubitemid 15192304)
2. McLatchie LM, Fraser NJ, Main M.J., Wise A., Brown J, Thompson N, Solari R., Lee MG, Foord SM. RAMPs regulate the transport and ligand specific-ity of the calcitonin-receptor-like receptor. Nature. 1998; 393: 333-339. (Pubitemid 28269699)
3. Smillie SJ, Brain SD Calcitonin gene-related peptide (CGRP) and its role in hypertension. Neuropeptides. 2011; 45: 93-104.
4. Brain SD, Grant AD Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004; 84: 903-934. (Pubitemid 38823770)
5. Olesen J, Diener HC, Husstedt I.W., Goadsby PJ, Hall D, Meier U, Pollentier S., Lesko LM; BIBN 4096 BS Clinical Proof of Concept Study Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004; 350: 1104-1110. (Pubitemid 38298990)
6. Ho AP, Dahlöf CG, Silberstein S.D., Saper Jr, Ashina M, Kost JT, Froman S, Leibensperger H., Lines CR, Ho TW. Randomized, controlled trial of telcagepant over four migraine attacks. Cephalalgia. 2010; 30: 1443-1457.
7. Mair J, Lechleitner P, Längle T, Wiedermann C., Dienstl F, Saria A. Plasma CGRP in acute myocardial infarction. Lancet. 1990; 335: 168. (Pubitemid 20032764)
8. Huang R, Karve A, Shah I., Bowers MC, DiPette DJ, Supowit SC, Abela GS Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2008; 294:H1291-H1297. (Pubitemid 351468726)
9. Li Y, Fiscus RR, Wu J, Yang L., Wang X. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells. Neuropeptides. 1997; 31: 503-509. (Pubitemid 27525144)
10. Wang W, Sun W, Wang X. Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta. Am J Physiol Heart Circ Physiol. 2004; 287:H1582-H1589. (Pubitemid 39313262)
11. Qin XP, Ye F, Hu C.P., Liao DF, Deng HW, Li YJ Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells. Eur J Pharmacol. 2004; 488: 45-49. (Pubitemid 38388522)
12. Haegerstrand A, Dalsgaard CJ, Jonzon B, Larsson O., Nilsson J. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci U S A. 1990; 87: 3299-3303.
13. Zhou Z, Hu CP, Wang C.J., Li TT, Peng J, Li YJ Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. Atherosclerosis. 2010; 213: 92-101.
14. Li J, Carnevale KA, Dipette D.J., Supowit SC Renal protective effects of α-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension. Am J Physiol Renal Physiol. 2013; 304:F1000-1008.
15. Bowers MC, Katki KA, Rao A, Koehler M., Patel P, Spiekerman A, DiPette D.J., Supowit SC. Role of calcitonin gene-related peptide in hypertension-induced renal damage. Hypertension. 2005; 46: 51-57. (Pubitemid 40946490)
16. Sabharwal R, Zhang Z, Lu Y., Abboud FM, Russo AF, Chapleau MW Receptor activity-modifying protein 1 increases barorefex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension. 2010; 55: 627-635.
17. Starr A, Graepel R, Keeble J., Schmidhuber S, Clark N, Grant A., Shah AM, Brain SD. A reactive oxygen species-mediated component in neuro-genic vasodilatation. Cardiovasc Res. 2008; 78: 139-147. (Pubitemid 351430963)
18. Graepel R, Fernandes ES, Aubdool A.A., Andersson DA, Bevan S, Brain SD 4-oxo-2-nonenal (4-ONE): evidence of transient receptor potential ankyrin 1-dependent and -independent nociceptive and vasoactive responses in vivo. J Pharmacol Exp Ther. 2011; 337: 117-124.
19. Salmon AM, Damaj I, Sekine S., Picciotto MR, Marubio L, Changeux JP Modulation of morphine analgesia in alphaCGRP mutant mice. Neuroreport. 1999; 10: 849-854. (Pubitemid 29393834)
20. Gangula PR, Zhao H, Supowit S.C., Wimalawansa SJ, Dipette DJ, Westlund KN, Gagel R.F., Yallampalli C. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. Hypertension. 2000; 35(1 pt 2): 470-475. (Pubitemid 30054218)
21. Li J, Wang DH Development of angiotensin II-induced hypertension: role of CGRP and its receptor. J Hypertens. 2005; 23: 113-118. (Pubitemid 40128988)
22. Yamada M, Ishikawa T, Fujimori A., Miyauchi T, Goto K. Enhanced depressor and hyperemic responses to calcitonin gene-related peptide in spontaneously hypertensive rats. Peptides. 1998; 19: 697-701. (Pubitemid 28255006)
23. Fujioka S, Sasakawa O, Kishimoto H., Tsumura K, Morii H. The anti-hypertensive effect of calcitonin gene-related peptide in rats with norepinephrine- and angiotensin II-induced hypertension. J Hypertens. 1991; 9: 175-179.
24. Supowit SC, Zhao H, Wang D.H., DiPette DJ Regulation of neuronal cal-citonin gene-related peptide expression. Role of increased blood pressure. Hypertension. 1995; 26(6 pt 2): 1177-1180.
25. Portaluppi F, Vergnani L, Margutti A., Ambrosio MR, Bondanelli M, Trasforini G, Rossi R., Degli Uberti EC. Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man. J Clin Endocrinol Metab. 1993; 77: 816-820. (Pubitemid 23298672)
26. Somasundaram C, Diz DI, Coleman T, Bukoski RD Adventitial neuronal somata. J Vasc Res. 2006; 43: 278-288. (Pubitemid 44257046)
27. Chrissobolis S, Zhang Z, Kinzenbaw D.A., Lynch CM, Russo AF, Faraci FM Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke. 2010; 41: 2329-2334.
28. Yang D, Luo Z, Ma S., Wong WT, Ma L, Zhong J, He H., Zhao Z, Cao T, Yan Z, Liu D, Arendshorst WJ, Huang Y, Tepel M, Zhu Z. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelax-ation and prevents hypertension. Cell Metab. 2010; 12: 130-141.
29. Li XW, Hu CP, Wu W.H., Zhang WF, Zou XZ, Li YJ Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27. Eur J Pharmacol. 2012; 679: 117-126.
30. Paravicini TM, Touyz RM NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008; 31(SUPPL. 2):S170-S180.
31. Wang HD, Pagano PJ, Du Y, Cayatte A.J., Quinn MT, Brecher P, Cohen RA Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res. 1998; 82: 810-818. (Pubitemid 28185849)
32. Shi Y, Niculescu R, Wang D., Patel S, Davenpeck KL, Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol. 2001; 21: 739-745. (Pubitemid 32448762)
33. Wind S, Beuerlein K, Armitage M.E., Taye A., Kumar AH, Janowitz D, Neff C, Shah A.M., Wingler K., Schmidt HH. Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension. 2010; 56: 490-497.
34. Haurani MJ, Cifuentes ME, Shepard A.D., Pagano PJ Nox4 oxidase over-expression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension. 2008; 52: 143-149.
35. Vera T, Kelsen S, Yanes L.L., Reckelhoff JF, Stec DE HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. Am J Physiol Regul Integr Comp Physiol. 2007; 292:R1472-R1478. (Pubitemid 46557809)
36. Weber DS, Rocic P, Mellis A.M., Laude K., Lyle AN, Harrison DG, Griendling KK Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2005; 288:H37-H42. (Pubitemid 40023825)
37. Ardanaz N, Yang XP, Cifuentes M.E., Haurani MJ, Jackson KW, Liao TD, Carretero O.A., Pagano PJ. Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension. Hypertension. 2010; 55: 116-123.
38. Hu CM, Chen YH, Chiang M.T., Chau LY Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. Circulation. 2004; 110: 309-316.
39. Chrissobolis S, Didion SP, Kinzenbaw D.A., Schrader LI, Dayal S, Lentz SR, Faraci FM Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction. Hypertension. 2008; 51: 872-877. (Pubitemid 351654698)
40. Li D, Peng J, Xin H.Y., Luo D., Zhang YS, Zhou Z, Jiang DJ, Deng H.W., Li YJ. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides. 2008; 29: 1781-1788.
41. Yang L, Sakurai T, Kamiyoshi A., Ichikawa-Shindo Y, Kawate H, Yoshizawa T., Koyama T, Iesato Y, Uetake R, Yamauchi A, Tanaka M, Toriyama Y, Igarashi K, Shindo T. Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury. J Mol Cell Cardiol. 2013; 59: 55-66.